Today's hearing provides us with an opportunity to examine perhaps one of the most important aspects of the 21st Century Cures Initiative: what does medical innovation or faster cures mean for patients. Keeping our work centered on the patient and understanding the patient perspective will bring much needed focus on results for patients who may lack adequate treatment options. Remember, there are only effective treatments for 500 of the 7,000 known diseases impacting patients today.
One of our witnesses today,
I want to welcome our witnesses today and look forward to learning more about the assessment of benefits and risks central to medical product development, regulations, and healthcare decision-making, and the tradeoffs between desired benefits and tolerable risks.
Read this original document at: http://energycommerce.house.gov/sites/republicans.energycommerce.house.gov/files/Hearings/Health/20140711/HHRG-113-IF14-MState-P000373-20140711.pdf
Most Popular Stories
- Why the Bond Market Isn't as Safe as You Think
- Lexus Luxury Compact Sedan Wins Buyers
- Review: Pay by Phone or Just Keep Using Plastic?
- Royals Beat A's in 12-inning Wild Card Thriller
- Dallas Parents Fear Students Exposed to Ebola
- What to Look for in Mich. Jobs Market
- Construction Spending Down Again for August
- Obama Seeks Traction From Economic Recovery
- Pickup Discounts Boost September Auto Sales
- N.Y. Ups Awards of State Contracts to Minorities